Economic studies Flashcards

1
Q

5 types of economic study

A
  1. cost minimisation
  2. cost effectiveness
  3. cost utility
  4. cost benefit
  5. cost consequences
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Direct costs

A

-costs of hospital space, cost of drugs, cost of equipment etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indirect costs

A

-costs due to loss of productivity for the patient, the cost of having a caretaker for one’s dog or nanny for a child when hospitalised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Intangible (not measurable costs)

A

-cost of pain and suffering, social stigma, physical discomfort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Opportunity cost

A

-cost of wasted opportunities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Economic benefits

A

-amount saved as a result of the prevention of illness and treatment, avoidance of admission, economic benefits of work, cost saved from quicker recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical benefits

A

-improvement in rating scale scores, life years gained and deaths prevented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The quality of life benefits

A

-improved general well being, improved perceived life quality, regain of functions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Health state preference values

A
  • the value that a person will place in a health state in a hypothetical situation
  • 4 main methods
    1. rating scales
    2. time trade-off measures
    3. standard gamble measures
    4. willingness to pay
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Rating scales for health state preference values

A
  • the respondent is asked to indicate along a line where would he place a particular health state
  • 0 refers to death, maximum point refers to perfect health
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Time trade-off measures

A

-how many of the remaining life years would a respondent spend in trying to get cured of a particular condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Standard gamble measures

A

-how much risk would an individual accept to get cured for a health problem where the intervention could cure or kill them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Willingness to pay

A

-how much people would be prepared to spend to prevent or cure a particular health state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cost minimisation study

A

-used when both interventions produce the same outcome and so just the costs are compared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cost effectiveness study

A

-used when both interventions result in an outcome that can be measured using the same clinical scale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cost utility study

A
  • used when apart from the clinical effect, one has also to consider holistically the disease burden, side effects and social impact
  • output is QOL, QALY
17
Q

Cost benefit study

A
  • used when two different interventions with different clinical outcomes are compared
  • in this case all the outcomes are translated into money terms and then compared
  • used by managers to decide how to spend allocated money effectively
18
Q

Cost consequences study

A
  • used when two different interventions with different clinical outcomes are compared but instead of combining costs into a common unit (like money or QALYS), natural units are used such as days saved, number of deaths prevented
  • also known as a disaggregated approach as outcomes on a balance sheet have different dimensions rather than a single net value
19
Q

Quality indicators of economic analyses

A
  1. viewpoints
  2. clinical effectiveness
  3. incremental values
  4. sensitivity analysis
20
Q

Viewpoints

A
  • conclusions of an economic analysis could vary based on who is estimating the costs vs benefits
  • the conclusion of an economic study must be interpreted in the context of the viewpoint employed in the analysis
21
Q

Clinical effectiveness

A

-compared interventions may be cheap but they have to work

22
Q

Incremental values

A

-incremental calculation must be done if two interventions are compared in an economic analysis and compares value for money

23
Q

Sensitivity analysis

A
  • in economic analysis it assumes the standard rate of inflation and discounts changes in foreign exchange
  • a conventional 6% discount rate is assumed year-on-year calculations
  • it is therefore important to check the effect of the outcome of a reported economic analysis by systematically examining what will happen if the assumptions are changed in one way
    1. one way analysis
    2. extreme scenario analysis
    3. two way analysis
    4. Monte-Carlo simulations
    5. Bootstrapping technique
24
Q

One-way analysis

A
  • change one variable in a manner plausible at a particular economic circumstance to observe the effect on the outcome
  • may underestimate the uncertainty
25
Q

Extreme scenario analysis

A
  • set one variable to either maximal or minimal values and examine the changes in the outcome
  • this overestimates the uncertainty
26
Q

Two-way analysis

A
  • two variables are changed simultaneously to observe the effects
  • might be cumbersome
27
Q

Monte-Carlo simulation

A

-the uncertainty in each utility is assumed to possess a probability distribution when estimating the predicted effects

28
Q

Bootstrapping technique

A
  • the effect of resampling the data set is investigated
  • the RCT on which an economic analysis is based gets repeated a large number of times
  • any variability in outcome depends on the precision of the originally reported results
29
Q

Cost Effectiveness Analysis

A
  • most popular in health care
  • average cost-effectiveness ratio ACER) is equal in cost/effect
  • Incremental cost-effectiveness ratio (ICER)- measure of the additional cost per unit of health gained
30
Q

ICER (incremental cost-effectiveness ratio

A

(the cost of the proposed intervention-cost of control intervention) /(the effect of proposed intervention-the effect of the control intervention)

31
Q

Incremental cost-effectiveness plane

A
  • shows the incremental cost and incremental effect visually
  • the horizontal axis divides the plane according to incremental cost and teh vertical axis divides the plane according to the incremental effect
  • each quadrant has a different implication for the decision
32
Q

ICER falls in NORTHWEST

A
  • positive costs and negative effects

- no use of the intervention

33
Q

ICER falls in SOUTHEAST

A
  • negative costs and positive effects

- intervention preferred

34
Q

ICER falls in NORTHEAST

A
  • positive effects and positive costs

- needs further consideration before acceptance

35
Q

ICER falls in SOUTHWEST

A
  • negative costs and negative effects
  • not clinically effective
  • needs further study
36
Q

Deciding ‘value for money’

A
  • ICER must be compared to the maximum amount that the decision maker is willing to pay for health effects ( maximum acceptable ceiling ratio)
  • probabilities of investment can be identified from the incremental cost-effectiveness plane with reference to the decision maker’s defined maximum acceptable ceiling ratio- uses a Cost-effectiveness acceptability curve= CEAC
37
Q

Cost-effectiveness acceptability curve

A
  • gives a probability that an intervention is cost-effective compared to the alternative, given the observed data for a range of willingness to pay values(lambda)
  • CEAC is a method of summarising the uncertainty in estimates of cost-effectiveness
38
Q

Nixon

A

-used a permutation matrix rather than a cost-effectiveness plane, but similar concept